Is vaping better than smoking for cardiorespiratory and muscle function?
Keywords:
Vaping, electronic cigarette, cardiorespiratory, lung function, smoking, muscle functionAbstract
Cigarette smoking is a risk factor for respiratory disorders, cardiovascular diseases and even decrements in muscle function. Electronic cigarette use (vaping) is considered a healthier alternative to cigarette smoking and may help in smoking cessation. However, the effects of vaping are not clear yet and particularly the long-term effects of vaping are largely unknown. Some reports suggest that vaping maybe as harmful for e.g. respiratory function, as cigarette smoking. In this narrative review the effects of vaping and cigarette smoking on respiratory, cardiovascular and muscle function are compared. Overall, vaping has been found to cause similar effects as smoking on lung function and cardiovascular function. Future studies are needed to clarify the severity of smoking- and vaping-induced decrements on muscle function.
References
World Health Organization. WHO report on the global tobacco epidemic, 2017: monitoring tobacco use and prevention policies. Geneva: World Health Organization; 2017.
Office for National Statistics. Adult smoking habits in the UK. London: Dandy Booksellers Ltd.; 2017.
Office for National Statistics. Adult smoking habits in the UK: 2018. Available from: https://www.ons.gov.uk/releases/adultsmokinghabitsintheuk2018
Lopez AD, Collishaw NE, Piha T. A descriptive model of the cigarette epidemic in developed countries. Tob Control 1994;3:242-7.
Heishman SJ, Kleykamp BA, Singleton EG. Meta-analysis of the acute effects of nicotine and smoking on human performance. Psychopharmacology (Berl) 2010;210:453-69.
Action on Smoking and Health. Use of e‐cigarettes (vapourisers) among adults in Great Britain. 2019. Available from: https://ash.org.uk/information-and-resources/fact-sheets/statistical/use-of-e-cigarettes-among-adults-in-great-britain-2019/
Korfei M. The underestimated danger of E-cigarettes - also in the absence of nicotine. Respir Res 2018;19:159.
Schraufnagel DE, Blasi F, Drummond MB, Lam DC, Latif E, Rosen MJ, et al. Electronic cigarettes. A position statement of the forum of International Respiratory Societies. Am J Respir Crit Care Med 2014;190:611-8.
Kuehn B. Vaping and pregnancy. JAMA 2019;321:1344.
McAlinden KD, Chan YL, Kota A, Chen H, Oliver BG, Sharma P. Maternal E-cigarette vaping enhances development of allergic asthma in the offspring. In: Proceedings Int Conf American Thoracic Society, 2017; Abstract A7333.
Orzabal MR, Lunde-Young ER, Ramirez JI, Howe SY, Naik VD, Lee J, et al. Chronic exposure to e-cig aerosols during early development causes vascular dysfunction and offspring growth deficits. Translat Res 2019;207:70-82.
Glantz SA, Forbes ER. The cigarette papers. Berkeley: University of California Press; 1996.
Ling PM, Glantz SA. Tobacco industry consumer research on socially acceptable cigarettes. Tob Control 2005;14:e3.
Lik H. Electronic atomization cigarette. US Patent US8393331B2; 2004.
Demick B. A high-tech approach to getting a nicotine fix. Los Angeles Times [Internet]; 2009. Available from: https://www.latimes.com/archives/la-xpm-2009-apr-25-fg-china-cigarettes25-story.html
Dutra LM, Grana R, Glantz SA. Philip Morris research on precursors to the modern e-cigarette since 1990. Tob Control 2017;26:e97-105.
Foulds J, Veldheer S. Commentary on Etter & Bullen (2011): Could E-cigs become the ultimate nicotine maintenance device? Addiction 2011;106:2029.
Etter J-F. Electronic cigarettes: a survey of users. BMC Public Health 2010;10:231.
Etter JF, Bullen C. Electronic cigarette: users profile, utilization, satisfaction and perceived efficacy. Addiction 2011;106:2017-28.
Dawkins L, Turner J, Roberts A, Soar K. ‘Vaping’profiles and preferences: an online survey of electronic cigarette users. Addiction 2013;108:1115-25.
Dockrell M, Morrison R, Bauld L, McNeill A. E-cigarettes: prevalence and attitudes in Great Britain. Nicotine Tob Res 2013;15:1737-44.
Farsalinos KE, Romagna G, Tsiapras D, Kyrzopoulos S, Voudris V. Evaluating nicotine levels selection and patterns of electronic cigarette use in a group of “vapers” who had achieved complete substitution of smoking. Subst Abuse 2013;7:139-46.
Filippidis FT, Laverty AA, Gerovasili V, Vardavas CI. Two-year trends and predictors of e-cigarette use in 27 European Union member states. Tob Control 2017;26:98-104.
Polosa R, Caponnetto P, Morjaria JB, Papale G, Campagna D, Russo C. Effect of an electronic nicotine delivery device (e-Cigarette) on smoking reduction and cessation: a prospective 6-month pilot study. BMC Public Health 2011;11:786.
Polosa R, Morjaria JB, Caponnetto P, Campagna D, Russo C, Alamo A, et al. Effectiveness and tolerability of electronic cigarette in real-life: a 24-month prospective observational study. Intern Emerg Med 2014;9:537-46.
Caponnetto P, Campagna D, Cibella F, Morjaria JB, Caruso M, Russo C, et al. EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study. PloS One 2013;8:e66317.
Hajek P, Phillips-Waller A, Przulj D, Pesola F, Myers Smith K, Bisal N, et al. A randomized trial of e-cigarettes versus nicotine-replacement therapy. N Engl J Med 2019;380:629-37.
Kempton SJ, Burish NM, Rao VK. Electronic cigarettes: have you asked your patients about vaping? Plast Reconstr Surg 2014;133:907e.
European Commission. Proposal for a Directive of the European Parliament and of the Council on the approximation of the laws, regulations and administrative provisions of the Member States concerning the manufacture, presentation and sale of tobacco and related products. Brussels: European Commission; 2012.
Hua M, Alfi M, Talbot P. Health-related effects reported by electronic cigarette users in online forums. J Med Internet Res 2013;15:e59.
Westenberger BJ. Evaluation of e-cigarettes. St Louis: Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Division of Pharmaceutical Analysis; 2009.
Cobb NK, Abrams D. E-cigarette or drug-delivery device. N Engl J Med. 2011;365(3):193-5.
Callahan-Lyon P. Electronic cigarettes: human health effects. Tob Control 2014;23:ii36-ii40.
Bressan RA, Crippa JA. The role of dopamine in reward and pleasure behaviour–review of data from preclinical research. Acta Psychiatr Scand 2005;111:14-21.
Benowitz NL. Nicotine addiction. N Engl J Med 2010;362:2295-303.
Cameron JM, Howell DN, White JR, Andrenyak DM, Layton ME, Roll JM. Variable and potentially fatal amounts of nicotine in e-cigarette nicotine solutions. Tob Control 2014;23:77-8.
Ordonez J, Forrester MB, Kleinschmidt K. Electronic cigarette exposures reported to poison centers. Clin Toxicol 2013;51:685.
Centers for Disease Control Prevention. Ingestion of cigarettes and cigarette butts by children--Rhode Island, January 1994-July 1996. MMWR Morb Mortal Wkly Rep 1997;46:125-8.
Thornton S, Oller L, Sawyer T, editors. Fatal intravenous injection of electronic “eLiquid” solution. Clin Toxicol 2013;51:683.177.
Valento M. Nicotine poisoning following ingestion of e-Liquid. Clin Toxicol 2013;51:683-4.
Christensen LB, van't Veen T, Bang J. Three cases of attempted suicide by ingestion of nicotine liquid used in e-cigarettes. Clin Toxicol 2013;51:290.85
Laugesen M. Second safety report on the Ruyan® e-cigarette. Cell 2008;27:4375.
Wieslander G, Norbäck D, Lindgren T. Exp.erimental exposure to propylene glycol mist in aviation emergency training: acute ocular and respiratory effects. Occup Environ Med 2001;58:649-55.
Choi H, Schmidbauer N, Sundell J, Hasselgren M, Spengler J, Bornehag C-G. Common household chemicals and the allergy risks in pre-school age children. PloS One 2010;5:e13423.
Goniewicz ML, Knysak J, Gawron M, Kosmider L, Sobczak A, Kurek J, et al. Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob Control 2014;23:133-9.
Cahn Z, Siegel M. Electronic cigarettes as a harm reduction strategy for tobacco control: a step forward or a repeat of past mistakes? J Public Health Policy 2011;32:16-31.
Harber P, Saechao K, Boomus C. Diacetyl-induced lung disease. Toxicol Rev 2006;25:261-72.
Rankin GD, Wingfors H, Uski O, Hedman L, Ekstrand‐Hammarström B, Bosson J, et al. The toxic potential of a fourth‐generation E‐cigarette on human lung cell lines and tissue explants. Journal of Applied Toxicology. 2019;39(8):1143-54.
Kim SA, Smith S, Beauchamp C, Song Y, Chiang M, Giuseppetti A, et al. Cariogenic potential of sweet flavors in electronic-cigarette liquids. PLoS One 2018;13:e0203717.
Talhout R, Schulz T, Florek E, van Benthem J, Wester P, Opperhuizen A. Hazardous compounds in tobacco smoke. Int J Environ Res Public Health 2011;8:613-28.
Williams M, Villarreal A, Bozhilov K, Lin S, Talbot P. Metal and silicate particles including nanoparticles are present in electronic cigarette cartomizer fluid and aerosol. PLoS One 2013;8:e57987.
Vardavas C, Tzatzarakis M, Vardavas A, Girvalaki C, Stivaktakis P, Nikolouzakis T, et al. Evaluation of respiratory irritants among the most popular e-cigarette refill liquids across 9 European countries. Eur Respir J 2017;50:OA1978.
Matt GE, Quintana PJ, Hoh E, Zakarian JM, Dodder NG, Record RA, et al. Persistent tobacco smoke residue in multiunit housing: Legacy of permissive indoor smoking policies and challenges in the implementation of smoking bans. Prev Med Rep 2020:101088.
Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004;350:2645-53.
Centers for Disease Control Prevention. How tobacco smoke causes disease: The biology and behavioral basis for smoking-attributable disease: A report of the surgeon general. Atlanta: Centers for Disease Control and Prevention; 2010.
Stănescu D, Sanna A, Veriter C, Kostianev S, Calcagni P, Fabbri L, et al. Airways obstruction, chronic expectoration, and rapid decline of FEV1 in smokers are associated with increased levels of sputum neutrophils. Thorax 1996;51:267-71.
Wüst RC, Degens H. Factors contributing to muscle wasting and dysfunction in COPD patients. Int J Chron Obstruct Pulmon Dis 2007;2:289.
Salvi SS, Barnes PJ. Chronic obstructive pulmonary disease in non-smokers. Lancet 2009;374:733-43.
Palazzolo DL. Electronic cigarettes and vaping: a new challenge in clinical medicine and public health. A literature review. Front Public Health 2013;1:56.
Vardavas CI, Anagnostopoulos N, Kougias M, Evangelopoulou V, Connolly GN, Behrakis PK. Short-term pulmonary effects of using an electronic cigarette: impact on respiratory flow resistance, impedance, and exhaled nitric oxide. Chest 2012;141:1400-6.
Flouris AD, Chorti MS, Poulianiti KP, Jamurtas AZ, Kostikas K, Tzatzarakis MN, et al. Acute impact of active and passive electronic cigarette smoking on serum cotinine and lung function. Inhal Toxicol 2013;25:91-101.
Hansson L, Choudry NB, Karlsson JA, Fuller RW. Inhaled nicotine in humans: effect on the respiratory and cardiovascular systems. J Appl Physiol (1985) 1994;76:2420-7.
Vakali S, Tsikrika S, Gennimata SA, Kaltsakas G, Palamidaw A, Koulouris N, et al. E-cigarette acute effect on symptoms and airways inflammation: Comparison of a nicotine containing with a non-nicotine device. Eur Respir J 2013;42:P1055.
Chaumont M, Bernard A, Pochet S, Melot C, El Khattabi C, Reye F, et al. High-wattage e-cigarettes induce tissue hypoxia and lower airway injury: A randomized clinical trial. Am J Respir Crit Care Med 2018;198:123-6.
Li D, Sundar IK, McIntosh S, Ossip DJ, Goniewicz ML, O’Connor RJ, et al. Association of smoking and electronic cigarette use with wheezing and related respiratory symptoms in adults: cross-sectional results from the Population Assessment of Tobacco and Health (PATH) study, wave 2. Tob Control 2020;29:140-7.
McCauley L, Markin C, Hosmer D. An unexpected consequence of electronic cigarette use. Chest 2012;141:1110-3.
Meo SA, Ansary MA, Barayan FR, Almusallam AS, Almehaid AM, Alarifi NS, et al. Electronic cigarettes: impact on lung function and fractional exhaled nitric oxide among healthy adults. Am J Mens Health 2019;13:1557988318806073.
Kiter G, Ucan E, Ceylan E, Kilinc O. Water-pipe smoking and pulmonary functions. Respir Med 2000;94:891-4.
Sparrow D, Stefos T, Bossé R, Weiss ST. The relationship of tar content to decline in pulmonary function in cigarette smokers. Am Rev Respir Dis 1983;127:56-8.
Polosa R, Cibella F, Caponnetto P, Maglia M, Prosperini U, Russo C, et al. Health impact of e-cigarettes: a prospective 3.5-year study of regular daily users who have never smoked. Sci Rep 2017;7:13825.
Wüst RC, Morse CI, De Haan A, Rittweger J, Jones DA, Degens H. Skeletal muscle properties and fatigue resistance in relation to smoking history. Eur J Appl Physiol 2008;104:103.
Glynos C, Bibli S-I, Katsaounou P, Pavlidou A, Magkou C, Karavana V, et al. Comparison of the effects of e-cigarette vapor with cigarette smoke on lung function and inflammation in mice. Am J Physiol Lung Cell Mol Physiol 2018;315:L662-72.
Lauria V, Sperandio E, de Sousa T, de Oliveira Vieira W, Romiti M, de Toledo Gagliardi A, et al. Evaluation of dose–response relationship between smoking load and cardiopulmonary fitness in adult smokers: A cross-sectional study. Rev Port Pneumol (2006). 2017;23(2):79-84.
de Borba AT, Jost RT, Gass R, Nedel FB, Cardoso DM, Pohl HH, et al. The influence of active and passive smoking on the cardiorespiratory fitness of adults. Multidiscip Respir Med 2014;9:34.
Misigoj-Durakovic M, Bok D, Soric M, Dizdar D, Durakovic Z, Jukic I. The effect of cigarette smoking history on muscular and cardiorespiratory endurance. J Addict Dis 2012;31:389-96.
Campisi R, Czernin J, Schöder H, Sayre JW, Marengo FD, Phelps ME, et al. Effects of long-term smoking on myocardial blood flow, coronary vasomotion, and vasodilator capacity. Circulation 1998;98:119-25.
Groppelli A, Giorgi D, Omboni S, Parati G, Mancia G. Persistent blood pressure increase induced by heavy smoking. J Hypertens 1992;10:495-9.
Celermajer DS, Sorensen KE, Gooch V, Spiegelhalter D, Miller O, Sullivan I, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992;340:1111-5.
Lekakis J, Papamichael C, Vemmos C, Nanas J, Kontoyannis D, Stamatelopoulos S, et al. Effect of acute cigarette smoking on endothelium-dependent brachial artery dilatation in healthy individuals. Am J Cardiol 1997;79:529-31.
Quillen JE, Rossen JD, Oskarsson HJ, Minor RL, Lopez JAG, Winniford MD. Acute effect of cigarette smoking on the coronary circulation: constriction of epicardial and resistance vessels. J Am Coll Cardiol 1993;22:642-7.
Skotsimara G, Antonopoulos A, Oikonomou E, Ioakeimidis N, Tsalamandris S, Georgakopoulos C, et al. Exposure to e-cigarette adversely affects blood pressure and heart rate in healthy individuals: A Systematic review and meta-analysis. Circulation 2018;138:A11507-A.
Yan XS, D'Ruiz C. Effects of using electronic cigarettes on nicotine delivery and cardiovascular function in comparison with regular cigarettes. Regul Toxicol Pharmacol 2015;71:24-34.
Battista L, Di Iorio M, Tancredi M, Acconcia MC, Torromeo C, Barillà F, et al. Cardiovascular effects of electronic cigarettes [abstract]. American Heart Association; 2013.
Benowitz NL, Fraiman JB. Cardiovascular effects of electronic cigarettes. Nat Rev Cardiol. 2017;14:447-56.
Chaumont M, de Becker B, Zaher W, Culié A, Deprez G, Mélot C, et al. Differential effects of e-cigarette on microvascular endothelial function, arterial stiffness and oxidative stress: A randomized crossover trial. Sci Rep 2018;8:10378.
Lundbäck M, Antoniewicz L, Brynedal A, Bosson J. Acute effects of active e-cigarette inhalation on arterial stiffness. Eur Respir J 2017;50:OA1979.
Antoniewicz L, Brynedal A, Hedman L, Lundbäck M, Bosson JA. Acute Effects of electronic cigarette inhalation on the vasculature and the conducting airways. Cardiovasc Toxicol 2019:1-10.
Shahab L, Goniewicz ML, Blount BC, Brown J, McNeill A, Alwis KU, et al. Nicotine, carcinogen, and toxin exposure in long-term e-cigarette and nicotine replacement therapy users: A cross-sectional study. Ann Intern Med 2017;166:390-400.
Caporale A, Langham MC, Guo W, Johncola A, Chatterjee S, Wehrli FW. Acute effects of electronic cigarette aerosol inhalation on vascular function detected at quantitative MRI. Radiology 2019;293:97-106.
Larsson L, Örlander J. Skeletal muscle morphology, metabolism and function in smokers and non‐smokers. A study on smoking‐discordant monozygous twins. Acta Physiol Scand 1984;120:343-52.
Degens H, Veerkamp J. Changes in oxidative capacity and fatigue resistance in skeletal muscle. Int J Biochem 1994;26:871-8.
Örlander J, Kiessling K-H, Larsson L. Skeletal muscle metabolism, morphology and function in sedentary smokers and nonsmokers. Acta Physiol Scand 1979;107:39-46.
Degens H, Gayan-Ramirez G, van Hees HW. Smoking-induced skeletal muscle dysfunction. From evidence to mechanisms. Am J Respir Crit Care Med 2015;191(620-5.
Petersen AMW, Magkos F, Atherton P, Selby A, Smith K, Rennie MJ, et al. Smoking impairs muscle protein synthesis and increases the expression of myostatin and MAFbx in muscle. Am J Physiol Endocrinol Metab 2007;293:E843-8.
Barreiro E, Peinado VI, Galdiz JB, Ferrer E, Marin-Corral J, Sanchez F, et al. Cigarette smoke–induced oxidative stress: a role in chronic obstructive pulmonary disease skeletal muscle dysfunction. Am J Respir Crit Care Med 2010;182:477-88.
Seymour J, Spruit M, Hopkinson N, Natanek S, Man W-C, Jackson A, et al. The prevalence of quadriceps weakness in COPD and the relationship with disease severity. Eur Respir J 2010;36:81-8.
Published
Issue
Section
License
Mattioli 1885 has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
How to Cite
